route92medical.comHealthcare / Medical DevicesFounded: 2015Funding to Date: $167.29MM
Route 92 Medical is a medical device company which offers neurovascular intervention technologies to healthcare providers and hospitals. Their product portfolio includes devices designed for the treatment of acute ischemic stroke and other cerebrovascular conditions. By developing innovative catheter-based technologies, Route 92 Medical aims to improve patient outcomes and potentially expand treatment options in neurovascular care. This company was founded by Tony Chou MD in 2015 and is headquartered in San Jose, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/28/2024 | Series F | $81.67MM | $xx.xx | $251.44MM | InnovaHealth Partners, Norwest Venture Partners, The Vertical Group, U.S. Venture Partners, Novo Holdings | |
Price per Share
$xx.xx
Shares Outstanding
11,446,879
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
InnovaHealth Partners, Norwest Venture Partners, The Vertical Group, U.S. Venture Partners, Novo Holdings
|
||||||
12/14/2021 | Series E | $56.14MM | $xx.xx | $156.52MM | InnovaHealth Partners, Norwest Venture Partners, The Vertical Group, U.S. Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
8,768,903
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
InnovaHealth Partners, Norwest Venture Partners, The Vertical Group, U.S. Venture Partners
|
||||||
05/13/2019 | Series D | $13MM | $xx.xx | $82.91MM | U.S. Venture Partners, The Vertical Group | |
Price per Share
$xx.xx
Shares Outstanding
2,030,900
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
U.S. Venture Partners, The Vertical Group
|
||||||
08/15/2018 | Series C | $4.73MM | $xx.xx | $50.49MM | U.S. Venture Partners, The Vertical Group | |
Price per Share
$xx.xx
Shares Outstanding
1,059,835
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
U.S. Venture Partners, The Vertical Group
|
||||||
04/20/2017 | Series B | $5.86MM | $xx.xx | $40.33MM | U.S. Venture Partners, The Vertical Group | |
Price per Share
$xx.xx
Shares Outstanding
1,672,985
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
U.S. Venture Partners, The Vertical Group
|
||||||
05/16/2016 | Series A | $5.9MM | $xx.xx | $19.67MM | U.S. Venture Partners, The Vertical Group | |
Price per Share
$xx.xx
Shares Outstanding
2,360,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
U.S. Venture Partners, The Vertical Group
|